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reLationSHiP betWeen PLaSma anD reD bLooD ceLL concentrationS  
of Quinine in braZiLian cHiLDren WitH uncomPLicateD Plasmodium falciparum  
maLaria on oraL tHeraPY
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SUMMARY
We determined the relationship between plasma and red blood cell concentrations of quinine in children with uncomplicated 
falciparum malaria from an endemic area of Amazonian region. Quinine was determined by high performance liquid chromatography 
with ultraviolet detection. In the steady state the ratio between plasma and red blood cell quinine concentration was 1.89 ± 1.25 ranging 
from 1.05 to 2.34. This result demonstrated that quinine do not concentrate in red blood cell of Brazilian children and characterize 
the absence of interracial difference in this relationship.
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In the last decade there has been an effort at monitoring the blood 
levels of antimalarials in patients with falciparum malaria, an important 
tool in the evaluation of efficacy and effectiveness of antimalarial drugs4,5. 
The response of the developing malaria parasite to antimalarials is largely 
determined by the concentration of drug accessible to the parasite within 
the red cell and its sensitivity to that drug4. The level of antimalarial drug 
in the plasma is proportional to the concentration within the parasitized 
red cell and it is determined by several independent variables as the 
drug formulation, age, race, immunity, the fraction of drug absorbed, 
the apparent volume of distribution and the clearance5,6,7.    
There is a lack of knowledge about the relationship between plasma 
and red blood cell concentrations of quinine in Brazilian children with 
uncomplicated falciparum malaria in which the standard treatment with 
oral quinine was used1. This is essential for the success of the treatment 
once a marked interpersonal and interracial difference in quinine 
disposition have been demonstrated3,4,5. Therefore, this work was done 
to elucidate this relationship in an endemic area of Amazon region, in a 
prospective clinical treatment trial.  
This study was conducted from January 2006 to January 2007, 
with 10 male children with signs and symptoms of uncomplicated P. 
falciparum malaria. Their characteristics were as follows (means ± SDs): 
age, 9.2 ± 3.1 years (age range; five to 13 years); body weight, 21.2 ± 
4.1 Kg, erythrocyte count, 3.21 ± 0.52 x 106/µL; white blood count, 
11,300 ± 4700/µL. The median initial parasitemia was 2100/µL (range; 
900 to 4500/µL). The patients were admitted to the public Hospital of 
Cachoeira do Piriá, Brazil. Informed consent was obtained from their 
parents. Children with severe or mixed malaria were excluded. Patients 
who had taken any antimalarial drugs within the previous 48 hours were 
also excluded. This study was approved by the ethics committee of the 
Tropical Medicine Center of Para Federal University. 
After clinical assessment and confirmation by microscopic 
examination of blood smears, all patients were treated with 3-day oral 
treatment regimen of quinine base (487.5 mg), followed by doxycycline 
hydrochloride for five days and primaquine phosphate in the last day. 
Reappearance of infection was assessed for at least 28 days, by clinical 
evaluation and microscopic examination of blood smears1,8.
Venous blood samples were taken for quinine level determination 
before and on the third day of treatment. All blood samples were taken 
immediately before the next dose, i.e were measured in different levels. 
The samples (3 mL) were collected in heparinized tubes and immediately 
centrifuged at 1500g for 15 minutes. The plasma and red blood cell 
samples were stored at -20 0C until analysis2. 
Quinine was analyzed by high performance liquid chromatography 
as described previously2. The analytical procedure validated in our 
laboratory demonstrated that within-day and day-to-day coefficients of 
variation were 6.7 and 8.1%, respectively. Mean extraction recovery of 
quinine was 95%. The stability of blank plasma spiked with quinine was 
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60 days in the conditions described above. Primaquine, doxycycline, 
mefloquine, amodiaquine, acetaminophen and chloroquine do not 
interfered in the detection of quinine2.  
All patients had been cured following the treatment and no 
recrudescence was observed after 28 days. The mean time for parasite 
clearance was 50.4 hours, with interval of 24 to 92 hours. 
All samples collected before starting the treatment were negative 
for quinine. The mean quinine concentration in children plasma samples 
in the steady state was 0.723 ± 0.6 µg/mL ranging from 0.219 to 1.59 
µg/mL. In red blood cell was 0.53 ± 0.88 µg/mL, ranging from 0.19 to 
0.948 µg/mL. 
The ratio between plasma and red blood cell quinine concentrations 
in steady state was 1.89 ± 1.25 ranging from 1.05 to 2.34. This result 
demonstrated that quinine do not concentrate in red blood cell of 
Brazilian children and demonstrates an absence of interracial differences 
in agreement with previous studies that show the ratio between the 
plasma and red blood cell quinine concentrations varied from 0.2 to 
2.3. The variability in this relation could be of therapeutic relevance, 
once the concentration of quinine in plasma and red blood cell must 
remain above levels which inhibit parasite multiplication throughout the 
course of treatment to eradicate the infection because there is a higher 
probability that a resistant strain will emerge if the drug is present at a 
sub therapeutic concentration3,4,7,8.
RESUMO
Relação entre as concentrações plasmáticas e eritrocitárias de 
quinina em crianças com malária por Plasmodium falciparum não 
complicada em terapia via oral
Neste estudo foi determinada a relação entre as concentrações 
plasmáticas e eritrocitárias de quinina em crianças com malária 
falciparum não complicada, oriundas de área endêmica da Região 
Amazônica. A quinina foi detrminada por cromatografia líquida de alta 
eficiência. No estado de equilíbrio, a relação foi 1,89 ± 1,25 variando 
de 1,05 a 2,34. Estes resultados demonstraram que a quinina não se 
concentra nos eritrócitos das crianças e caracterizaram a ausência de 
diferença racial nesta relação.
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